Dynamic changes of regulatory T cell and dendritic cell subsets in stable kidney transplant patients a prospective analysis

Iranian Journal of Kidney Diseases

Volumn 8, Issue 2, 2014, Pages 130-138

  Nikoueinejad, Hassan ^a   Amirzargar, Aliakbar ^a   Sarrafnejad, Abdolfattah ^a   Einollahi, Behzad ^b   Nafar, Mohsen ^c   Ahmadpour, Pedram ^c   Pour Reza Gholi, Fatemeh ^c   Sehat, Omid ^d   Lesanpezeshki, Mahboob ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dendritic cells; Kidney Transplantation; Regulatory T lymphocytes

Indexed keywords

CD45 ANTIGEN; CREATININE; TRANSCRIPTION FACTOR FOXP3; ALLOANTIBODY; BIOLOGICAL MARKER; HLA ANTIGEN;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; DENDRITIC CELL; FAMILY RELATION; FEMALE; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; IMMUNE STATUS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYELOID DENDRITIC CELL; ORGAN DONOR; PLASMACYTOID DENDRITIC CELL; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; REGULATORY T LYMPHOCYTE; BLOOD; CLINICAL TRIAL; HISTOCOMPATIBILITY; IMMUNOLOGY; IRAN; LONGITUDINAL STUDY; METABOLISM; MULTICENTER STUDY; TIME; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GLOMERULAR FILTRATION RATE; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; IRAN; ISOANTIBODIES; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84897859114     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342:605-12.
2. Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int. 2002;62:311-8.
3. Furness PN, Philpott CM, Chorbadjian MT, et al. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates. Transplantation. 2003;76:969-73.
4. Hernandez-Fuentes MP, Lechler RI. A 'biomarker signature' for tolerance in transplantation. Nat Rev Nephrol. 2010;6:606-13.
5. Sagoo P, Perucha E, Sawitzki B, et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest. 2010;120:1848-61.
6. Sanchez-Fueyo A, Strom TB. Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology. 2011;140:51-64.
7. Solgi G, Furst D, Mytilineos J, Pourmand G, Amirzargar AA. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA. Transpl Immunol. 2012;26:81-7.
8. Mohammadnia M, Solgi G, Ranjbar M, et al. Serum levels of interleukin (IL)-10, IL-17, transforming growth factor (TGF)-beta1, and interferon-gamma cytokines and expression levels of IL-10 and TGF-beta1 genes in renal allograft recipients after donor bone marrow cell infusion. Transplant Proc. 2011;43:495-9.
9. Nazari B, Amirzargar A, Nikbin B, et al. Comparison of the Th1, IFN-gamma secreting cells and FoxP3 expression between patients with stable graft function and acute rejection post kidney transplantation. Iran J Allergy Asthma Immunol. 2013;12:262-8.
10. Solgi G, Gadi V, Paul B, et al. Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survival. Chimerism. 2013;4:87-94.
11. Mohammadi F, Niknam MH, Nafar M, et al. Dynamic changes of IFN-γ-producing cells, TGF-β and their predictive value in early outcomes of renal transplantation. Int J Org Transplant Med. 2013;4;77-85.
12. Waldmann H, Adams E, Fairchild P, Cobbold S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol Rev. 2006;212:301-13.
13. Jiang S, Lechler RI, He XS, Huang JF. Regulatory T cells and transplantation tolerance. Hum Immunol. 2006;67:765-76.
14. Shan J, Guo Y, Luo L, et al. Do CD4+ Foxp3+ Treg cells correlate with transplant outcomes: a systematic review on recipients of solid organ transplantation. Cell Immunol. 2011;270:5-12.
15. Ranjbar M, Solgi G, Mohammadnia M, et al. Regulatory T-cell subset analysis and profile of interleukin (IL)-10, IL-17 and interferon-gamma cytokine-producing cells in kidney allograft recipients with donor cells infusion. Clin Exp Nephrol. 2012;16:636-46.
16. Merad M, Collin M, Bromberg J. Dendritic cell homeostasis and trafficking in transplantation. Trends Immunol. 2007;28:353-9.
17. Ezzelarab M, Thomson AW. Tolerogenic dendritic cells and their role in transplantation. Semin Immunol. 2011;23:252-63.
18. Solari MG, Thomson AW. Human dendritic cells and transplant outcome. Transplantation. 2008;85:1513-22.
19. Velasquez-Lopera MM, Eaton VL, Lerret NM, et al. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells. Transpl Immunol. 2008;19:127-35.
20. Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med. 2005;353:2342-51.
21. Salama AD, Najafian N, Clarkson MR, Harmon WE, Sayegh MH. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol. 2003;14: 1643-51.
22. Louis S, Braudeau C, Giral M, et al. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation. 2006;81:398-407.
23. Veronese F, Rotman S, Smith RN, et al. Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection. Am J Transplant. 2007;7:914-22.
24. Bestard O, Cruzado JM, Mestre M, et al. Achieving donorspecific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol. 2007;179:4901-9.
25. Braudeau C, Racape M, Giral M, et al. Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl Int. 2007;20:845-55.
26. Akl A, Jones ND, Rogers N, et al. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. Transpl Int. 2008;21:65-73.
27. Ehser S, Chuang JJ, Kleist C, et al. Suppressive dendritic cells as a tool for controlling allograft rejection in organ transplantation: promises and difficulties. Hum Immunol. 2008;69:165-73.
28. Albert ML, Jegathesan M, Darnell RB. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol. 2001;2:1010-7.
29. Verhasselt V, Vosters O, Beuneu C, Nicaise C, Stordeur P, Goldman M. Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells. Eur J Immunol. 2004;34:762-72.
30. Karczewski M, Karczewski J, Kostrzewa A, Wiktorowicz K, Glyda M. The role of Foxp3+ regulatory T cells in kidney transplantation. Transplant Proc. 2009;41:1527-9.
31. Karczewski J, Karczewski M, Wiktorowicz K. Possible defect of T suppressor cell subpopulation in patients with kidney acute rejection. Transplant Proc. 2010;42:4538-9.
32. Kim SH, Oh EJ, Ghee JY, et al. Clinical significance of monitoring circulating CD4+CD25+ regulatory T cells in kidney transplantation during the early posttransplant period. J Korean Med Sci. 2009;24 Suppl:S135-S142.
33. Kawai M, Kitade H, Mathieu C, Waer M, Pirenne J. Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo. Transplantation. 2005;79:1073-7.
34. Zeiser R, Nguyen VH, Beilhack A, et al. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurindependent interleukin-2 production. Blood. 2006;108: 390-9.
35. Pino-Lagos K, Michea P, Sauma D, et al. Cyclosporin A-treated dendritic cells may affect the outcome of organ transplantation by decreasing CD4+CD25+ regulatory T cell proliferation. Biol Res. 2010;43:333-7.
36. Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood. 2005;105:4743-8.
37. Demirkiran A, Kok A, Kwekkeboom J, et al. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl. 2006;12:277-84.
38. Braudeau C, Racape M, Giral M, et al. Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl Int 2007;20:845.
39. Chen X, Oppenheim JJ, Winkler-Pickett RT, Ortaldo JR, Howard OM. Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur J Immunol. 2006;36:2139-49.
40. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol. 2001;167:1945-53.
41. Fangmann J, Wegmann C, Hoppe A, et al. Characterization of dendritic cell subsets in patients undergoing renal transplantation. Transplant Proc. 2007;39:3101-4.
42. Womer KL, Peng R, Patton PR, et al. The effects of renal transplantation on peripheral blood dendritic cells. Clin Transplant. 2005;19:659-67.
43. Womer KL, Peng R, Patton PR, et al. The effects of renal transplantation on circulating precursor dendritic cells. Transplant Proc. 2005;37:3-6.
44. Hesselink DA, Vaessen LM, Hop WC, et al. The effects of renal transplantation on circulating dendritic cells. Clin Exp Immunol. 2005;140:384-93.
45. Boor PP, Metselaar HJ, Mancham S, Tilanus HW, Kusters JG, Kwekkeboom J. Prednisolone suppresses the function and promotes apoptosis of plasmacytoid dendritic cells. Am J Transplant. 2006;6:2332-41.
46. Hackstein H, Renner FC, Bohnert A, et al. Dendritic cell deficiency in the blood of kidney transplant patients on long-term immunosuppression: results of a prospective matched-cohort study. Am J Transplant. 2005;5:2945-53.
47. Shodell M, Shah K, Siegal FP. Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration. Lupus. 2003;12:222-30.
48. Ochando JC, Homma C, Yang Y, et al. Alloantigenpresenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol. 2006;7:652-62.
49. Tokita D, Mazariegos GV, Zahorchak AF, et al. High PDL1/ CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation. 2008;85:369-77.
50. Li XL, Menoret S, Bezie S, et al. Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance. J Immunol. 2010;185:823-33.
51. Maldonado RA, von Andrian UH. How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol. 2010;108:111-65.